The objective was to determine the stability of premixed injectable atropine sulfate samples with different expiration dates. METHODS: This was an in-vitro study using gas chromatography and mass ...
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of myopia in children. Considered a common ...
The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results